Hexadimethrine bromide was used for the neutralization of heparin during cardiac surgery in the late 1950s. For some years, this institution has used it for patients who may be allergic to protamine. In view of the recent renewal of interest in hexadimethrine, we present four cases outlining its use during cardiac procedures in such patients. Other drugs for reversing the action of heparin such as heparinase or platelet factor IV are not yet widely available.
Protamine is usually used for neutralization of heparin after cardiopulmonary bypass (CPB). It is not suitable for use in some patients, such as those who may have had significant previous allergic reactions to either intravenous protamine or protaminecontaining insulin preparations. The overall incidence of adverse reactions to protamine has been quoted as 10.7%, with 1.6% having severe cardiovascular reactions 1 . Alternatives to protamine include heparinase 2 and recombinant platelet factor IV (rPF4) 3 , neither of which is widely available.
Hexadimethrine bromide (Polybrene) is a polycation that was introduced into clinical practice in 1954 and was used extensively for neutralization of heparin after CPB. In 1962, it was reported to cause proteinuric renal failure if given in excessive amounts 4 and its use was largely curtailed. It was recommended for use in protamine-allergic patients by Doolan in 1981 1 . There have been two recent in vitro studies comparing it favourably with other agents for the reversal of heparin 5, 6 .
At the Royal Perth Hospital (RPH), hexadimethrine is used for neutralization of heparin in patients who have suffered adverse reactions related to the administration of protamine. Hexadimethrine, which is used as a reagent for the blood cross-matching process, is made as a 1% solution in water (400 mg in 40 ml) which is then sterile-filtered through a 0.2 micron filter in the Pharmacy Department. This process takes about 15 minutes. It is administered slowly, at a dose of 0.7mg to neutralize 1mg (1000 IU) heparin, to a maximum of 5 mg/kg.
We describe four patients from the RPH database who had hexadimethrine during cardiac surgery. These patients required reversal of heparin but had had an adverse reaction probably due to protamine. The cases occurred within the past five years and represent the practice of different clinicians. Due to the retrospective nature of the search, some data regarding coagulation profiles could not be retrieved.
CASE 1
A 55-year-old woman with severe rheumatic mitral regurgitation and pulmonary hypertension was scheduled for elective mitral valve replacement and tricuspid annuloplasty. The patient remained stable throughout the pre-bypass period. Following the administration of heparin 450 mg, the activated clotting time (ACT) was 658 seconds. The surgery was uncomplicated with a bypass time of 99 minutes. After weaning from CPB the patient was stable with a systolic blood pressure (SBP) of 90 to 100 mmHg. Immediately following administration of 400 mg of protamine, the SBP fell to 30 mmHg and the pulmonary artery pressure increased. This responded satisfactorily to adrenaline 1 mg and noradrenaline 0.5 mg, followed by infusions of both inotropes.
In the intensive care unit, her coagulation profile showed an international normalized ration (INR) of 1.4 and thromboplastin time (APTT) of 68.2 seconds. In view of the previous reaction associated with the administration of protamine, hexadimethrine 400 mg was used to reverse the remaining effects of the heparin. There were no adverse effects. A repeat APTT following this was 30.3 seconds. Her further postoperative course was uneventful with no evidence of renal dysfunction as measured by creatinine concentration.
CASE 2
A 67-year-old man with a history of triple vessel coronary artery disease and normal left ventricular function was scheduled to have coronary artery bypass grafts (CABG). The patient was a non-insulin dependent diabetic on metformin. He had not had protamine-containing insulin.
The patient was haemodynamically stable before and on weaning from CPB. Heparin 400 mg had been given and protamine 200 mg was slowly administered. The SBP fell to 40 mmHg and the airway pressures increased. Normotension was rapidly restored with adrenaline followed by high-dose noradrenaline infusion. Methylprednisolone was given for the presumed anaphylactic reaction to the protamine. ACT measurements after protamine were not recorded, but due to the heparin/protamine ratio of 2:1 and continued blood loss, hexadimethrine 400 mg was given. There were no adverse effects and the patient had an uneventful postoperative course, with no deterioration in renal function.
CASE 3
A 74-year-old man with a history of myocardial infarction now presenting with unstable angina was scheduled for CABG. The case proceeded without problems. Heparin 400 mg was given. Four-vessel CABG was performed. The patient was stable until approximately ten minutes after receiving protamine 400 mg. There was a marked fall in blood pressure which was treated with adrenaline, but ventricular fibrillation ensued. Cardiac massage was started, a further 750 mg of heparin was given and CPB restarted. The patient was weaned from CPB but required a high dose adrenaline infusion to maintain blood pressure. An intra-aortic balloon pump was inserted. Hexadimethrine 400mg was administered in theatre. The patient's inotropic requirements were reduced by the aortic balloon pump and the patient's condition improved over the next few hours. A further 50 mg of hexadimethrine was administered in the intensive care unit to correct a high APTT without any adverse effects. There was no indication of renal toxicity postoperatively.
CASE 4
A 61-year-old man with a history of myocardial infarction and recent crescendo angina was scheduled for CABG. The surgery proceeded without problems. Heparin 350 mg prior to CPB produced an ACT of 623 seconds. After decannulation and administration of protamine 400 mg, the patient's haemoglobin oxygen saturation decreased and there was a progressive fall in SBP to 50 mmHg. The patient was anticoagulated again with heparin 400 mg and CPB re-instituted as an emergency. The anaesthetist considered that the episode may have been due to an anaphylactic reaction to protamine and the patient was treated with adrenaline, methylprednisolone and promethazine. The patient was stabilized and after decannulation the second time, hexadimethrine 400 mg was administered. Follow-up ACT was not documented. The patient returned to the ICU stable with inotropic support. Soon after arrival in the ICU he again became hypotensive with raised pulmonary artery pressures and was returned to the operating theatre for insertion of a left ventricular assist device. This was unsuccessful and the patient died on the operating table.
DISCUSSION
The use of protamine is associated with a number of complications. Cardiovascular collapse may be related to rapid administration of protamine or true anaphylaxis. There are no widely available alternatives for the neutralization of heparin in patients who may be sensitive to protamine. Hexadimethrine bromide (hexadimethrine) is a stable quaternary ammonium salt, which has been shown, both in vitro and in vivo, to be more potent than protamine in reversing the effects of heparin 2, 7 . It was introduced for clinical use in 1956. Weiss et al in 1957 described the use of hexadimethrine in awake volunteers as well as in 87 patients undergoing cardiac surgery requiring heparinization 8 . This study showed the effectiveness of hexadimethrine for neutralization of heparin and a favourable side-effect profile. Side-effects included transient reversible hypotension and evidence of bronchoconstriction in the awake volunteers. Weiss concluded that hexadimethrine was the most controllable heparin neutralizing agent, with less severe and more transient hypotensive episodes than protamine or toluidine blue. Blumberg et al in 1960 cited 47 cases in which hexadimethrine was used effectively and described it as being a superior drug to protamine due to its stability, rapid action, uniformity of potency A. COONEY, T. J. MANN Anaesthesia and Intensive Care, Vol. 27, No. 3, June1999 and absence of severe hypotensive reactions. He declared that hexadimethrine was to be used routinely in preference to protamine for open heart surgery in his practice 9 .
There is sparse published data to indicate whether hexadimethrine became established in clinical practice following its introduction. However enthusiasm for its use reduced following reports in 1962 and 1965 of acute renal failure (ARF) in patients who received hexadimethrine in doses greater than 5 mg/kg during cardiac surgery 4,10 . Hunsicker et al in 1981 showed that the ARF was reversible and postulated that neutralization of glomerular basement membrane anions altered charge-dependent permeability of the glomerulus, resulting in proteinuria 11 . Experimentally it was found that the onset of proteinuria was blocked by infusion of heparin 12 .
In 1981, hexadimethrine was advocated for neutralization of heparin in patients with documented protamine allergy 1 . At Royal Perth Hospital (RPH) hexadimethrine has been used in such patients for many years. In 1996, Kikura et al compared hexadimethrine with methylene blue and vancomycin for neutralization of heparin, and recommended that the use of hexadimethrine be further investigated 5 . Mochizuki et al evaluated the effects of protamine, PF4 and hexadimethrine on the ACT of heparinized blood after CPB, and found that hexadimethrine demonstrated a wider therapeutic margin than protamine in prolonging the ACT at excessive dosages 6 . There has not been a comparison of hexadimethrine with other alternatives to protamine such as rPF4 or heparinase in vivo.
Although other alternatives to protamine such as rPF4 and heparinase may become available, hexadimethrine, in appropriate doses of less than 5 mg/kg, remains a viable alternative to protamine in cases where protamine is likely to cause adverse reactions.
